Citigroup Inc

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
CIK
0000831001
Manager Name
Citigroup Inc
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions
Manager:
SEC
Search and click to pin securities to the top
Page 224 of 239
ACHIEVE LIFE SCIENCES, INC.
ACHV|004468500
Shares:
342(+434.4%)
Value:
$913.0K(+305.8%)
VERU INC.
VERU|92536C103
Shares:
1853(+207.8%)
Value:
$908.0K(+131.6%)
450047303
450047303
Shares:
70(+0.0%)
Value:
$903.0K(-13.6%)
AUDIOEYE INC
AEYE|050734201
Shares:
81(+575.0%)
Value:
$899.0K(+391.3%)
Larimar Therapeutics, Inc.
LRMR|517125100
Shares:
418(-98.3%)
Value:
$898.0K(-99.1%)
Adverum Biotechnologies, Inc.
ADVM|00773U207
Shares:
205(+439.5%)
Value:
$896.0K(+406.2%)
Kronos Bio, Inc.
KRON|50107A104
Shares:
1078
Value:
$889.0K
Cabaletta Bio, Inc.
CABA|12674W109
Shares:
633(+383.2%)
Value:
$876.0K(+194.9%)
TAYLOR DEVICES, INC.
TAYD|877163105
Shares:
27(+575.0%)
Value:
$871.0K(+424.7%)
Waldencast plc
WALD|G9503X103
Shares:
289(+186.1%)
Value:
$867.0K(+113.5%)
Septerna, Inc.
SEPN|81734D104
Shares:
149(-99.0%)
Value:
$863.0K(-99.7%)
Upstream Bio, Inc.
UPB|91678A107
Shares:
141(-99.5%)
Value:
$863.0K(-99.8%)
EGAIN Corp
EGAN|28225C806
Shares:
176(+402.9%)
Value:
$854.0K(+291.7%)
Nanobiotix S.A.
NBTX|63009J107
Shares:
241(+0.0%)
Value:
$853.0K(+23.3%)
Cardlytics, Inc.
CDLX|14161W105
Shares:
468(+115.7%)
Value:
$852.0K(+5.7%)
ATOSSA THERAPEUTICS, INC.
ATOS|04962H506
Shares:
1263(+432.9%)
Value:
$850.0K(+279.5%)
Neumora Therapeutics, Inc.
NMRA|640979100
Shares:
850(-99.1%)
Value:
$850.0K(-99.9%)
MARKETWISE, INC.
MKTW|57064P107
Shares:
1721(+19.5%)
Value:
$849.0K(+3.9%)
Lineage Cell Therapeutics, Inc.
LCTX|53566P109
Shares:
1869(+384.2%)
Value:
$844.0K(+335.1%)
NL INDUSTRIES INC
NL|629156407
Shares:
105(+176.3%)
Value:
$830.0K(+181.3%)